Budget Impact Analysis of Introducing the New Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir for the Treatment of Hiv in Portugal
AuthID
P-005-8A8
P-005-8A8
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service